Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Grant - II | Dead

Total Raised


Last Raised


About IPBio

Developer of methodologies for the introduction of molecules into viable cells and the repair of genetic defects. The company's technology enables the transfer of genetic material into cells, working a wide variety of mammalian cells, including mono-layers and suspensions, with high transfection rates and minimal cell mortality. The company's technology can transfect a particular cell type out of a mixture of cells and takes around three to six hours to transfect cells. The company's technology also enables other macromolecules such as proteins to enter cells.

IPBio Headquarter Location

Chartway Street

ME17 3HX,

United Kingdom

44 162 284 2297

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.